Alexandre Loupy

👨‍⚕️#Nephrologist M.D. Head of @parisTxgroup. PhD #1 in Cell Biology 🧫 PhD #2 in Biostatistics 📊. Passionate about improving #Patient Care by #innovation

[Alexandre Loupy @AlexandreLoupy]

30 institutions participating in this Trial
Grateful to this amazing network !!!

[Alexandre Loupy @AlexandreLoupy]

@KSusztak @GbadegesinLab bravo !

[JHLT @TheJHLT]

A new study identifies 7 distinct FEV1 trajectories post #LungTransplantation, each telling a different story of survival- should we consider personalized, trajectory-based monitoring of lung recipients? 🫁 @Raynaud_Maths, @drAntoineRoux, @AlexandreLoupy

🔗: https://t.co/gbToCt5aYv

[Alexandre Loupy @AlexandreLoupy]

@ChangUCanSpare 🦾

[NEJM @NEJM]

CONFIDENCE trial: In persons with chronic kidney disease and type 2 diabetes, combination therapy with finerenone and empagliflozin led to a greater reduction in the urinary albumin-to-creatinine ratio than either drug alone. Full trial results and Research Summary: https://t.co/4Gf0LboOCp

[Alexandre Loupy @AlexandreLoupy]

@WashUNephrology @HumphreysLab @jclinicalinvest @WashUDeptMed Warm congratulations !

[Alexandre Loupy @AlexandreLoupy]

@Tobias_B_Huber @PuellesVictor @UKEHamburg @AarhusUni @Nature Bravo !!!!

[Paris Transplant Group @ParisTxGroup]

📢 Just out in @NatureComms & presented @ESOTtransplant !
Our study "Impact of HLA evolutionary divergence and molecular mismatches on AMR of kidney allografts" is now published.
🔗https://t.co/JbOwg6vtIL
🙌to @zpdemir2
Carmen Lefaucheur @AlexandreLoupy

[Alexandre Loupy @AlexandreLoupy]

🔬 A look at the top-tier journals in medicine and biomedical science interesting! congratulation on these top tier journals🚀🦾🚀🤩
•The Lancet IF: 98.4
•NEJM IF: 96.2
•The BMJ IF: 93.6
•Nature Medicine IF: 50.0
•JAMA IF: 50.0
•Nature IF: 48.5

[Alexandre Loupy @AlexandreLoupy]

From @ESOTtransplant #esotcongress 2025 2 amazing days working with colleagues on the @TheLancet commission. Paving the future of organ transplantation in the next 15 years !!!

[Alexandre Loupy @AlexandreLoupy]

Great thing about having the Lancet commission meeting ahead of #ESOT2025 is that you can see an empty congress space quiet before the storm ! looking forward to meeting with colleagues and friends and share science !! @gabriel_oniscu

[Marc Raynaud 🇫🇷 @Raynaud_Maths]

📢 New publication in Xenotransplantation Journal by our group @ParisTxGroup @AlexandreLoupy !

Among the 2,900+ Xeno papers we assessed, 706 focused on solid organ & islet transplants from animals to humans 🐷➡️🧍

https://t.co/oVmg6r0HeC

Here’s a summary of what we found 👇

[ASN Publications @asnpublications]

Beyond standard of care monitoring for patients who are post-transplant, urinary chemokine CXCL9 demonstrated limited clinical utility, while CXCL10 provided no additional value. https://t.co/M5nBEwbVkS #ASNJASN

[Alexandre Loupy @AlexandreLoupy]

🚀🚀

[Alexandre Loupy @AlexandreLoupy]

Direct from Choose Europe 🇪🇺for Science: A Bold Step from Paris 🇫🇷 !
Transplant researchers: if you’re ready to innovate, 🇫🇷 might be your next destination🛬.
@ParisTxGroup is ready 🚀🤖🦾#PITOR #FranceForScience DM me if interested

[Alexandre Loupy @AlexandreLoupy]

@VineetaKumar8 @amjtransplant @AST_info @AST_LDCOP well deserved !

[Alexandre Loupy @AlexandreLoupy]

@KristaLentine @CEOatNKF @nkf @NKF_NephPros @AST_info @RachelPatzerPhD @LorrindaD @ThePower2Save @slusom @SSMHealthSTL @WIT_TTS ❤️🚀🦾

[Alexandre Loupy @AlexandreLoupy]

@KristaLentine @AST_info @SumitMohanMD @EpiSnyder @beaukellymd @gracelyden @ThePower2Save @SSMHealthSTL @slusom @SRTRNews ❤️🚀

[Alexandre Loupy @AlexandreLoupy]

❤️

[Alexandre Loupy @AlexandreLoupy]

Thank you 🙏 for an amazing event and so many bright people ! go Mayo !

[Sandra Herrmann MD, FASN @HerrmannMd]

@MayoClinicNeph , Hypertension and Kidney Transplantation Update for the Clinician 2025 from Kidney stones to AI in Tx fantastic presentations @AlexandreLoupy @keddis_mira @lieske_john

[Alexandre Loupy @AlexandreLoupy]

@SethiRenalPath @AnilaCara @GianMarcoB65728 🦾